% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • boardwalk97 boardwalk97 Apr 2, 2013 10:51 AM Flag

    Lunch short bread

    Meniscus transplants growing in popularity
    meniscus transplant could provide relief for about 10 years on average, allowing younger patients to postpone a knee replacement until later in life.
    Slowly the whole biologic field is growing, growing in acceptance as well," Stone said.

    While meniscus replacement may be gaining wider acceptance, it's still controversial among many surgeons, including some who argue the technique is too risky.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • monarch6500 Apr 2, 2013 12:09 PM Flag

      Any thoughts on how the Grafix sales force is doing?

      Sentiment: Strong Buy

      • 1 Reply to monarch6500
      • clinicaltrials dot gov.....plug in OSIRIS and the trial is listed.

        Even though past treatment data is overwhelmingly positive, sales revenues hinge on this trial to provide basis for treatment of DFU with Medicare ins. Seems illogical, but it's the way of the healthcare world....illogical, fraudulent and an enormously bewildering. Considering the many other wounds and burns needing treatment, perhaps Medicare funded healthcare becomes less relevant.

        I'm sure there is preliminary trial data available as indicated with OSIR building its sales force. So positive.

        Sentiment: Strong Buy

5.61-0.26(-4.43%)Apr 29 4:00 PMEDT